Comparative in vitro activity of A-56268 against respiratory tract pathogens
暂无分享,去创建一个
[1] H. Neu,et al. Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria , 1987, Antimicrobial Agents and Chemotherapy.
[2] S. Finegold,et al. Antimicrobial resistance in Bacteroides. , 1987, The Journal of antimicrobial chemotherapy.
[3] R. Jones,et al. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin , 1987, Antimicrobial Agents and Chemotherapy.
[4] L. Ayers,et al. Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates , 1986, Antimicrobial Agents and Chemotherapy.
[5] H. Neu,et al. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074) , 1986, Antimicrobial Agents and Chemotherapy.
[6] F. Ahmad,et al. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections , 1984, Antimicrobial Agents and Chemotherapy.
[7] L. Peterson,et al. MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques , 1984, Antimicrobial Agents and Chemotherapy.
[8] N. Ampel,et al. Comparison of tube dilution and microtitre methods for the detection of antibiotic tolerance in strains of Staphylococcus aureus. , 1984, The Journal of antimicrobial chemotherapy.
[9] A. Forsgren,et al. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983. , 1984, Acta oto-laryngologica. Supplementum.
[10] G. Donowitz,et al. Empiric therapy for pneumonia. , 1983, Reviews of infectious diseases.
[11] G. Doern,et al. Antibiotic Susceptibility of Beta-Lactamase-Producing Strains of Branhamella (Neisseria) catarrhalis , 1980, Antimicrobial Agents and Chemotherapy.
[12] D. Citron,et al. Wadsworth Anaerobic Bacteriology Manual , 1980 .